- Home
- RVPHW vs EFSCP Comparison
RVPHW vs EFSCP Comparison
Compare RVPHW & EFSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPHW
- EFSCP
- Stock Information
- Founded
- RVPHW 2018
- EFSCP N/A
- Country
- RVPHW United States
- EFSCP United States
- Employees
- RVPHW N/A
- EFSCP 1221
- Industry
- RVPHW Biotechnology: Pharmaceutical Preparations
- EFSCP Major Banks
- Sector
- RVPHW Health Care
- EFSCP Finance
- Exchange
- RVPHW Nasdaq
- EFSCP Nasdaq
- Market Cap
- RVPHW N/A
- EFSCP N/A
- IPO Year
- RVPHW N/A
- EFSCP N/A
- Fundamental
- Price
- RVPHW $0.12
- EFSCP $19.67
- Analyst Decision
- RVPHW
- EFSCP
- Analyst Count
- RVPHW 0
- EFSCP 0
- Target Price
- RVPHW N/A
- EFSCP N/A
- AVG Volume (30 Days)
- RVPHW 22.4K
- EFSCP N/A
- Earning Date
- RVPHW 03-14-2025
- EFSCP N/A
- Dividend Yield
- RVPHW N/A
- EFSCP N/A
- EPS Growth
- RVPHW N/A
- EFSCP N/A
- EPS
- RVPHW N/A
- EFSCP N/A
- Revenue
- RVPHW N/A
- EFSCP N/A
- Revenue This Year
- RVPHW N/A
- EFSCP N/A
- Revenue Next Year
- RVPHW N/A
- EFSCP N/A
- P/E Ratio
- RVPHW N/A
- EFSCP N/A
- Revenue Growth
- RVPHW N/A
- EFSCP N/A
- 52 Week Low
- RVPHW $0.13
- EFSCP N/A
- 52 Week High
- RVPHW $0.15
- EFSCP N/A
- Technical
- Relative Strength Index (RSI)
- RVPHW N/A
- EFSCP 47.24
- Support Level
- RVPHW N/A
- EFSCP $19.69
- Resistance Level
- RVPHW N/A
- EFSCP $19.86
- Average True Range (ATR)
- RVPHW 0.00
- EFSCP 0.15
- MACD
- RVPHW 0.00
- EFSCP -0.02
- Stochastic Oscillator
- RVPHW 0.00
- EFSCP 5.10
About RVPHW Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About EFSCP Enterprise Financial Services Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of 5% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate, and consumer loans.